Physician profile
Megan Hull
NPI 1700208469
$1,925.71
in general payments reported to CMS, 2019-2025
24 companies · $618 in 2025
The $618 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $304 · 2022: $357 · 2023: $334 · 2024: $313 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240 · Grant: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.63 |
| Grant | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $305.71 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $299.91 | 2024-2025 | Indigo System, Penumbra System |
| Janssen Pharmaceuticals, INC | $233.43 | 2021-2023 | Xarelto |
| Cardiva Medical, INC. | $152.47 | 2022-2025 | Cardiva Vascade 6/7f Vcs |
| Organogenesis INC. | $143.85 | 2021-2023 | Puraply Antimicrobial |
| Boston Scientific Corporation | $142.15 | 2023-2025 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Varithena Administration Pack |
| Silk Road Medical, INC. | $132.00 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $76.15 | 2021-2023 | |
| W. L. Gore & Associates, INC. | $72.56 | 2021-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Smith+Nephew, INC. | $57.45 | 2022-2025 | Stravix, Renasys Go V2 Home, Renasys Touch |
| Ethicon US, LLC | $47.03 | 2022-2025 | Vistaseal, Surgicel Nu-Knit, Ethicon |
| Kci USA, INC. | $40.59 | 2021-2022 | |
| Integra Lifesciences Corporation | $28.69 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Terumo Medical Corporation | $23.60 | 2022 | |
| Philips North America LLC | $23.53 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $20.85 | 2025 | |
| Haemonetics Corporation | $20.38 | 2025 | Teg6s Hemostasis System |
| Sanara Medtech INC. | $18.39 | 2023 | Celleraterx |
| Arjo INC. | $17.89 | 2024 | |
| Lemaitre Vascular, INC. | $16.77 | 2023 | Artegraft Vascular Graft |
| Bard Peripheral Vascular, INC. | $16.50 | 2022 | |
| Argon Medical Devices, INC. | $12.81 | 2022 | |
| Aroa Biosurgery Incorporated | $11.69 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Hull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.